← Leaderboards
Fenyong Liu
University Of California Berkeley
$19,674,021
Attributed
$19,674,021
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$19,674,021 · 10
By mechanism
R01$19,495,380 · 9
R29$178,641 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Berkeley
Same institution · by research overlap
- Britt A Glaunsinger$11,913,528
- David W Morgens$487,581
- Joel L Sachs$55,915
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusVirus DiseasesInfectionIn VitroViralNovel StrategiesGrowthAcquired Immunodeficiency SyndromeMutantCellsInsightBiological ModelsCytomegalovirus InfectionsOpen Reading FramesGenesGene ExpressionViral GenesMouth DiseasesAnimal ModelAntiviral AgentsTherapeutic AgentsTissuesReportingVirus Replication
Grant awards (66)
Persistent infection of human cytomegalovirus in oral mucosa$497,081
R01 · FY2019 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$495,064
R01 · FY2018 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$70,108
R01 · FY2018 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$9,111
R01 · FY2018 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$454,557
R01 · FY2017 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$453,828
R01 · FY2017 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$21,862
R01 · FY2017 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$454,557
R01 · FY2016 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$383,257
R01 · FY2016 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$485,164
R01 · FY2015 · DE · contact PI
Persistent infection of human cytomegalovirus in oral mucosa$383,257
R01 · FY2015 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$30,510
R01 · FY2015 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$391,250
R01 · FY2014 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$63,156
R01 · FY2014 · DE · contact PI
Human cytomegalovirus chromatin modifications in oral infection$391,250
R01 · FY2013 · DE · contact PI
Cytomegalovirus virulence in immunodeficient hosts$353,547
R01 · FY2013 · AI · contact PI
Cytomegalovirus virulence in immunodeficient hosts$429,571
R01 · FY2012 · AI · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$364,467
R01 · FY2012 · AI · contact PI
Cytomegalovirus virulence in immunodeficient hosts$376,113
R01 · FY2011 · AI · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$364,807
R01 · FY2011 · AI · contact PI
Cytomegalovirus virulence in immunodeficient hosts$379,913
R01 · FY2010 · AI · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$368,825
R01 · FY2010 · AI · contact PI
Small RNA therapeutics for AIDS-associated infection$324,810
R01 · FY2010 · DE · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$372,781
R01 · FY2009 · AI · contact PI
Cytomegalovirus virulence in immunodeficient hosts$361,524
R01 · FY2009 · AI · contact PI
Small RNA therapeutics for AIDS-associated infection$328,090
R01 · FY2009 · DE · contact PI
Cytomegalovirus infection in oral cavity$320,709
R01 · FY2009 · DE · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$171,651
R01 · FY2009 · AI · contact PI
Cytomegalovirus infection in oral cavity$373,281
R01 · FY2008 · DE · contact PI
Ribozymes for studies and treatment of cytomegalovirus infections$358,792
R01 · FY2008 · AI · contact PI
Small RNA therapeutics for AIDS-associated infection$328,090
R01 · FY2008 · DE · contact PI
AIDS-associated viral infections in human oral tissues$320,709
R01 · FY2008 · DE · contact PI
AIDS-associated viral infections in human oral tissues$324,277
R01 · FY2007 · DE · contact PI
Cytomegalovirus infection in oral cavity$324,277
R01 · FY2007 · DE · contact PI
Small RNA therapeutics for AIDS-associated infection$319,130
R01 · FY2007 · DE · contact PI
Cytomegalovirus infection in oral cavity$53,156
R01 · FY2007 · DE · contact PI
Cytomegalovirus infection in oral cavity$333,962
R01 · FY2006 · DE · contact PI
AIDS-associated viral infections in human oral tissues$333,962
R01 · FY2006 · DE · contact PI
Ribozymes for studies and treatment of HCMV infections$296,856
R01 · FY2006 · AI · contact PI
Cytomegalovirus virulence in immunodeficient hosts$296,856
R01 · FY2006 · AI · contact PI
AIDS-associated viral infections in human oral tissues$342,000
R01 · FY2005 · DE
Cytomegalovirus infection in oral cavity$329,000
R01 · FY2005 · DE
Cytomegalovirus virulence in immunodeficient hosts$304,000
R01 · FY2005 · AI
Cytomegalovirus infection of blood vessels$304,000
R01 · FY2005 · HL
Ribozymes for studies and treatment of HCMV infections$304,000
R01 · FY2005 · AI
Cytomegalovirus virulence in immunodeficient hosts$304,000
R01 · FY2004 · AI
Cytomegalovirus infection of blood vessels$304,000
R01 · FY2004 · HL
Small RNA-based agents for AIDS opportunistic infections$304,000
R01 · FY2004 · DE
Ribozymes for studies and treatment of HCMV infections$304,000
R01 · FY2004 · AI
Cytomegalovirus Infections in Oral Cavity$244,776
R01 · FY2004 · DE
Cytomegalovirus infection of blood vessels$304,000
R01 · FY2003 · HL
Small RNA-based agents for AIDS opportunistic infections$304,000
R01 · FY2003 · DE
Cytomegalovirus virulence in immunodeficient hosts$303,833
R01 · FY2003 · AI
Cytomegalovirus Infections in Oral Cavity$244,776
R01 · FY2003 · DE
Ribozymes for studies and treatment of HCMV infections$156,800
R01 · FY2003 · AI
Cytomegalovirus infection of blood vessels$292,850
R01 · FY2002 · HL
Small RNA-based agents for AIDS opportunistic infections$292,700
R01 · FY2002 · DE
Cytomegalovirus virulence in immunodeficient hosts$292,370
R01 · FY2002 · AI
Cytomegalovirus Infections in Oral Cavity$244,776
R01 · FY2002 · DE
RIBOZYMES FOR STUDIES AND TREATMENT OF HCMV INFECTIONS$219,026
R01 · FY2002 · AI
Cytomegalovirus Infections in Oral Cavity$237,745
R01 · FY2001 · DE
RIBOZYMES FOR STUDIES AND TREATMENT OF HCMV INFECTIONS$219,026
R01 · FY2001 · AI
SMALL NOVEL RNA AGENTS FOR HCMV THERAPY$183,573
R01 · FY2001 · AI
RIBOZYMES FOR STUDIES AND TREATMENT OF HCMV INFECTIONS$212,978
R01 · FY2000 · AI
SMALL NOVEL RNA AGENTS FOR HCMV THERAPY$178,983
R01 · FY2000 · AI
RNASE P RIBOZYMES FOR ANTIVIRAL APPLICATIONS$178,641
R29 · FY2000 · GM